Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance.

Samaras K, Viardot A, Lee PN, Jenkins A, Botelho NK, Bakopanos A, Lord RV, Hayward CS.

Diab Vasc Dis Res. 2013 Jan;10(1):40-8. doi: 10.1177/1479164112443375. Epub 2012 Apr 25.

PMID:
22535587
2.

The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes.

Viardot A, Lord RV, Samaras K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2845-50. doi: 10.1210/jc.2009-2371. Epub 2010 Apr 7.

PMID:
20375213
3.

Defective regulation of adipose tissue autophagy in obesity.

Nuñez CE, Rodrigues VS, Gomes FS, Moura RF, Victorio SC, Bombassaro B, Chaim EA, Pareja JC, Geloneze B, Velloso LA, Araujo EP.

Int J Obes (Lond). 2013 Nov;37(11):1473-80. doi: 10.1038/ijo.2013.27. Epub 2013 Mar 12.

PMID:
23478428
4.

Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G.

J Clin Endocrinol Metab. 2011 Jan;96(1):200-9. doi: 10.1210/jc.2010-0994. Epub 2010 Oct 13.

PMID:
20943784
5.

Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.

Nannipieri M, Cecchetti F, Anselmino M, Camastra S, Niccolini P, Lamacchia M, Rossi M, Iervasi G, Ferrannini E.

Int J Obes (Lond). 2009 Sep;33(9):1001-6. doi: 10.1038/ijo.2009.140. Epub 2009 Jul 28. Erratum in: Int J Obes (Lond). 2010 Jan;34(1):215.

PMID:
19636322
6.

Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.

Gumbs AA, Modlin IM, Ballantyne GH.

Obes Surg. 2005 Apr;15(4):462-73. Review.

PMID:
15946423
7.

Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.

Samaras K, Botelho NK, Chisholm DJ, Lord RV.

Obesity (Silver Spring). 2010 May;18(5):884-9. doi: 10.1038/oby.2009.443. Epub 2009 Dec 17.

8.

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.

Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M.

Metabolism. 2012 May;61(5):706-14. doi: 10.1016/j.metabol.2011.10.008. Epub 2011 Dec 2.

PMID:
22136911
9.

Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance.

Colman E, Katzel LI, Rogus E, Coon P, Muller D, Goldberg AP.

Metabolism. 1995 Nov;44(11):1502-8.

PMID:
7476341
10.

Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.

Saiki A, Ohira M, Endo K, Koide N, Oyama T, Murano T, Watanabe H, Miyashita Y, Shirai K.

Metabolism. 2009 May;58(5):708-13. doi: 10.1016/j.metabol.2009.01.013.

PMID:
19375596
11.

Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis.

Yoshida Y, Hashimoto N, Tokuyama Y, Kitagawa H, Takahashi K, Yagui K, Kanatsuka A, Bujo H, Higurashi M, Miyazawa S, Yoshida S, Saito Y.

Metabolism. 2004 Sep;53(9):1095-100.

PMID:
15334366
12.

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G.

Int J Obes (Lond). 2005 Jul;29(7):766-71.

PMID:
15917853
13.

Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.

Dadson P, Landini L, Helmiö M, Hannukainen JC, Immonen H, Honka MJ, Bucci M, Savisto N, Soinio M, Salminen P, Parkkola R, Pihlajamäki J, Iozzo P, Ferrannini E, Nuutila P.

Diabetes Care. 2016 Feb;39(2):292-9. doi: 10.2337/dc15-1447. Epub 2015 Dec 17.

PMID:
26681717
14.

Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.

Viljanen AP, Lautamäki R, Järvisalo M, Parkkola R, Huupponen R, Lehtimäki T, Rönnemaa T, Raitakari OT, Iozzo P, Nuutila P.

Ann Med. 2009;41(2):152-60. doi: 10.1080/07853890802446754.

PMID:
18855190
15.

Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin.

Murdolo G, Hammarstedt A, Sandqvist M, Schmelz M, Herder C, Smith U, Jansson PA.

J Clin Endocrinol Metab. 2007 Jul;92(7):2688-95. Epub 2007 Apr 24.

PMID:
17456576
16.

Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.

Chacón MR, Fernández-Real JM, Richart C, Megía A, Gómez JM, Miranda M, Caubet E, Pastor R, Masdevall C, Vilarrasa N, Ricard W, Vendrell J.

Obesity (Silver Spring). 2007 Mar;15(3):664-72.

17.

CCNG2 and CDK4 is associated with insulin resistance in adipose tissue.

Garrido-Sánchez L, Roca-Rodríguez Mdel M, Fernández-Veledo S, Vendrell J, Yubero-Serrano EM, Ocaña-Wilhelmi L, García-Fuentes E, Tinahones FJ.

Surg Obes Relat Dis. 2014 Jul-Aug;10(4):691-6. doi: 10.1016/j.soard.2013.12.011. Epub 2014 Jan 9.

PMID:
24708911
18.

The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.

Kovacova Z, Tencerova M, Roussel B, Wedellova Z, Rossmeislova L, Langin D, Polak J, Stich V.

Int J Obes (Lond). 2012 Oct;36(10):1360-5. doi: 10.1038/ijo.2011.223. Epub 2011 Dec 6.

PMID:
22143618
19.

Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.

Nannipieri M, Bonotti A, Anselmino M, Cecchetti F, Madec S, Mancini E, Baldi S, Santini F, Pinchera A, Rossi M, Ferrannini E.

Int J Obes (Lond). 2007 Dec;31(12):1843-8. Epub 2007 Jul 3.

PMID:
17607322
20.

Obesity is associated with activated and insulin resistant immune cells.

Viardot A, Heilbronn LK, Samocha-Bonet D, Mackay F, Campbell LV, Samaras K.

Diabetes Metab Res Rev. 2012 Jul;28(5):447-54. doi: 10.1002/dmrr.2302. Epub 2012 Apr 10.

PMID:
22492715

Supplemental Content

Support Center